TY - JOUR
T1 - Id1 transcription inhibitor-matrix metalloproteinase 9 axis enhances invasiveness of the breakpoint cluster region/Abelson tyrosine kinase-transformed leukemia cells
AU - Nieborowska-Skorska, Margaret
AU - Hoser, Grazyna
AU - Rink, Lori
AU - Malecki, Maciej
AU - Kossev, Plamen
AU - Wasik, Mariusz A.
AU - Skorski, Tomasz
PY - 2006/4/15
Y1 - 2006/4/15
N2 - Breakpoint cluster region/Abelson (BCR/ABL) tyrosine kinase enhances the ability of leukemia cells to infiltrate various organs. We show here that expression of the helix-loop-helix transcription factor Id1 is enhanced by BCR/ABL in a signal transducer and activator of transcription 5 (STAT5)-dependent manner. Enhanced expression of Id1 plays a key role in BCR/ ABL-mediated cell invasion. Down-regulation of Id1 in BCR/ABL leukemia cells by the antisense cDNA significantly reduced their invasive capability through the Matrigel membrane and their ability to infiltrate hematopoietic and nonhematopoietic organs resulting in delayed leukemogenesis in mice. The Id1-promoted cell invasiveness was seemingly mediated by matrix metalloproteinase 9 (MMP9). Transactivation of MMP9 promoter in BCR/ABL cells was dependent on Id1 and abrogation of the MMP9 catalytic activity by a metalloproteinase inhibitor or blocking antibody decreased invasive capacity of leukemia cells. These data suggest that BCR/ABL-STAT5-Id1-MMP9 pathway may play a critical role in BCR/ABL-mediated leukemogenesis by enhancing invasiveness of leukemia cells.
AB - Breakpoint cluster region/Abelson (BCR/ABL) tyrosine kinase enhances the ability of leukemia cells to infiltrate various organs. We show here that expression of the helix-loop-helix transcription factor Id1 is enhanced by BCR/ABL in a signal transducer and activator of transcription 5 (STAT5)-dependent manner. Enhanced expression of Id1 plays a key role in BCR/ ABL-mediated cell invasion. Down-regulation of Id1 in BCR/ABL leukemia cells by the antisense cDNA significantly reduced their invasive capability through the Matrigel membrane and their ability to infiltrate hematopoietic and nonhematopoietic organs resulting in delayed leukemogenesis in mice. The Id1-promoted cell invasiveness was seemingly mediated by matrix metalloproteinase 9 (MMP9). Transactivation of MMP9 promoter in BCR/ABL cells was dependent on Id1 and abrogation of the MMP9 catalytic activity by a metalloproteinase inhibitor or blocking antibody decreased invasive capacity of leukemia cells. These data suggest that BCR/ABL-STAT5-Id1-MMP9 pathway may play a critical role in BCR/ABL-mediated leukemogenesis by enhancing invasiveness of leukemia cells.
KW - Animals
KW - Cell Transformation, Neoplastic/metabolism
KW - Fusion Proteins, bcr-abl
KW - Hematopoietic Stem Cells/metabolism
KW - Inhibitor of Differentiation Protein 1/biosynthesis
KW - Leukemia, Experimental/enzymology
KW - Matrix Metalloproteinase 9/metabolism
KW - Mice
KW - Mice, SCID
KW - Neoplasm Invasiveness
KW - Promoter Regions, Genetic
KW - Protein-Tyrosine Kinases/genetics
KW - STAT5 Transcription Factor/metabolism
KW - Transcriptional Activation
UR - http://www.scopus.com/inward/record.url?scp=33646244743&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000236843200022&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1158/0008-5472.CAN-05-1584
DO - 10.1158/0008-5472.CAN-05-1584
M3 - Article
C2 - 16618731
SN - 0008-5472
VL - 66
SP - 4108
EP - 4116
JO - Cancer Research
JF - Cancer Research
IS - 8
ER -